Skip to search formSkip to main contentSkip to account menu

ovarian serous cystadenocarcinoma

Known as: serous cystadenocarcinoma ovary, ovarian cancer, serous cystadenocarcinoma, cystadenocarcinoma ovary serous 
A malignant serous cystic epithelial neoplasm arising from the ovary. It is characterized by the presence of glandular, papillary, or solid… 
National Institutes of Health

Related topics

Related topics

14 relations
Adenocarcinoma Cell with Intracytoplasmic MucinCystic ChangeEndometrial CarcinomaEpithelial Cells

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
The role of the fallopian tube in the origin of ovarian cancer.
Review
2013
Review
2013
Origin and molecular pathogenesis of ovarian high-grade serous carcinoma.
A new paradigm for the pathogenesis of ovarian cancer has recently been proposed which helps to explain persistent problems in… 
Highly Cited
2005
Highly Cited
2005
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis: A Mutational Analysis With…
The infrequent association of serous borderline tumors (SBTs) with invasive serous carcinoma has led to the view that SBTs are… 
Highly Cited
2005
Highly Cited
2005
Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors): Outcome-Based Study of 276 Patients With Long-Term (≥5-Year) Follow-Up
The natural history, classification, and nomenclature of ovarian serous tumors of low malignant potential (S-LMP) (serous tumors… 
Review
2004
Review
2004
Cystic Pancreatic Neoplasms: Observe or Operate
Objective:The objectives of this analysis were to define the incidence, natural history, and predictors of neoplasia in… 
Highly Cited
2001
Highly Cited
2001
Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study.
PURPOSE To evaluate the efficacy of carboplatin plus paclitaxel in primarily advanced or recurrent endometrial cancers… 
Review
2000
Review
2000
CT of primary cystic pancreatic neoplasms: can CT be used for patient triage and treatment?
OBJECTIVE The purpose of this study was to determine whether CT can be used to distinguish serous cystadenomas from mucinous… 
Review
1999
Review
1999
Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association.
OBJECTIVE To review the features of patients with benign and malignant cystadenomas of the pancreas, focusing on preoperative… 
Highly Cited
1995
Highly Cited
1995
The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.
Chemokines may control the macrophage infiltrate found in many solid tumors. In human ovarian cancer, in situ hybridization… 
Highly Cited
1993
Highly Cited
1993
Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.
The gene for tumor necrosis factor, TNF, was expressed in 45 out of 63 biopsies of human epithelial ovarian cancer. In serous… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)